These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11706602)

  • 21. Family genetics.
    Barlow-Stewart K; Gaff C; Emery J; Metcalfe SA
    Aust Fam Physician; 2007 Oct; 36(10):802-5. PubMed ID: 17925899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of neurological disorders.
    Faghihi MA; Mottagui-Tabar S; Wahlestedt C
    Expert Rev Mol Diagn; 2004 May; 4(3):317-32. PubMed ID: 15137899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Huntington disease: presymptomatic testing, prenatal diagnosis, preimplantation genetic diagnosis experience].
    Durr A; Viville S
    Gynecol Obstet Fertil; 2007 Oct; 35(10):1051-4. PubMed ID: 17897866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington's disease.
    Jasper MJ; Hu DG; Liebelt J; Sherrin D; Watson R; Tremellen KP; Hussey ND
    Fertil Steril; 2006 Mar; 85(3):597-602. PubMed ID: 16500325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing in gastroenterology: Lynch syndrome.
    Grover S; Syngal S
    Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia.
    Miossec-Chauvet E; Mikaeloff Y; Heron D; Merzoug V; Cormier-Daire V; de Lonlay P; Matthijs G; Van Hulle C; Ponsot G; Seta N
    Neuropediatrics; 2003 Feb; 34(1):1-6. PubMed ID: 12690561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive genetic testing in minors for adult-onset genetic diseases.
    Borry P; Goffin T; Nys H; Dierickx K
    Mt Sinai J Med; 2008; 75(3):287-96. PubMed ID: 18704981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fertility intentions following testing for a BRCA1 gene mutation.
    Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset triple A syndrome: a risk of overlooked or delayed diagnosis and management.
    Salmaggi A; Zirilli L; Pantaleoni C; De Joanna G; Del Sorbo F; Koehler K; Krumbholz M; Huebner A; Rochira V
    Horm Res; 2008; 70(6):364-72. PubMed ID: 18953174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The interpreter role of clinical geneticist in the process of genetic testing].
    Franková V
    Cas Lek Cesk; 2007; 146(11):840-3. PubMed ID: 18069209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk.
    Madlensky L; McLaughlin JR; Carroll JC; Goel V; Frank JW
    J Clin Epidemiol; 2005 Sep; 58(9):934-41. PubMed ID: 16085197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
    Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
    Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
    Langbehn DR; Brinkman RR; Falush D; Paulsen JS; Hayden MR;
    Clin Genet; 2004 Apr; 65(4):267-77. PubMed ID: 15025718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maturity of judgement in decision making for predictive testing for nontreatable adult-onset neurogenetic conditions: a case against predictive testing of minors.
    Richards FH
    Clin Genet; 2006 Nov; 70(5):396-401. PubMed ID: 17026621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why test children for adult-onset genetic diseases?
    Rhodes R
    Mt Sinai J Med; 2006 May; 73(3):609-16. PubMed ID: 16758099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.
    Shannon KM; Lubratovich ML; Finkelstein DM; Smith BL; Powell SN; Seiden MV
    Cancer; 2002 Jan; 94(2):305-13. PubMed ID: 11900216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [All that neurologist would like to know about sensitivity, specificity and predictive values].
    Gomez de la Camara A
    Neurologia; 2003 Dec; 18 Suppl 2():11-8. PubMed ID: 14669103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in genetic diagnosis of neurological disorders.
    Toft M
    Acta Neurol Scand Suppl; 2014; (198):20-5. PubMed ID: 24588502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic counseling issues in predictive genetic testing for familial adult-onset neurologic diseases.
    Burson CM; Markey KR
    Semin Pediatr Neurol; 2001 Sep; 8(3):177-86. PubMed ID: 11575847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.